04/23/2026
AXDEV is pleased to announce a new study published in ’s JBMRplus!
Can earlier recognition of rare diseases prevent avoidable harm?
Our latest research highlights gaps in HCP awareness of fibrodysplasia ossificans progressiva (FOP) and identifies key barriers to diagnosis, referral, and care.
This study was made possible with the support of IPSEN Biopharmaceuticals Inc.
Read the full article: https://doi.org/10.1093/jbmrpl/ziag076